U.S. Physical Therapy (NYSE:USPH) Research Coverage Started at JMP Securities

JMP Securities began coverage on shares of U.S. Physical Therapy (NYSE:USPH) in a research note published on Monday morning, MarketBeat reports. The firm issued an outperform rating and a $113.00 target price on the stock.

Other research analysts have also recently issued research reports about the stock. Barrington Research restated an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the company from $100.00 to $115.00 in a report on Monday. Finally, JPMorgan Chase & Co. upped their price target on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $114.00.

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock opened at $92.43 on Monday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a market capitalization of $1.40 billion, a price-to-earnings ratio of 98.33, a price-to-earnings-growth ratio of 4.23 and a beta of 1.46. The business has a 50-day moving average of $90.02 and a 200 day moving average of $89.80. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.90%. The ex-dividend date was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 1,172 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the sale, the director now owns 1,112 shares of the company’s stock, valued at approximately $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Eric Joseph Williams sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $95.84, for a total transaction of $191,680.00. Following the sale, the insider now owns 14,814 shares of the company’s stock, valued at $1,419,773.76. This represents a 11.89 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 7,412 shares of company stock worth $706,605 over the last ninety days. Corporate insiders own 1.70% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

Several large investors have recently bought and sold shares of the stock. State Street Corp boosted its holdings in shares of U.S. Physical Therapy by 17.5% in the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after acquiring an additional 99,244 shares during the period. Renaissance Technologies LLC raised its position in U.S. Physical Therapy by 763.7% in the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock valued at $6,425,000 after purchasing an additional 61,474 shares during the last quarter. Southernsun Asset Management LLC boosted its stake in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock worth $46,302,000 after purchasing an additional 52,062 shares during the period. Penn Davis Mcfarland Inc. purchased a new position in U.S. Physical Therapy during the 3rd quarter worth $2,552,000. Finally, Rockefeller Capital Management L.P. grew its position in U.S. Physical Therapy by 18.8% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 160,441 shares of the company’s stock worth $13,578,000 after purchasing an additional 25,393 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.